AARD
Aardvark Therapeutics Inc
NASDAQ · Pharmaceuticals
$12.65
+1.36 (+12.05%)
Open$11.61
Previous Close$11.29
Day High$13.03
Day Low$11.51
52W High$34.69
52W Low$17.03
Volume—
Avg Volume404.1K
Market Cap275.43M
P/E Ratio22.39
EPS$1.07
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+107.4% upside
Current
$12.65
$12.65
Target
$26.24
$26.24
$21.03
$26.24 avg
$41.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.31M | 42.19M | 44.45M |
| Net Income | 12.13M | 10.07M | 10.99M |
| Profit Margin | 27.4% | 23.9% | 24.7% |
| EBITDA | 17.61M | 17.80M | 18.44M |
| Free Cash Flow | 9.43M | 7.96M | 8.12M |
| Rev Growth | -1.8% | +11.1% | +14.2% |
| Debt/Equity | 0.60 | 0.62 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |